Search

everythinglearnresearchcommunity

for

Search:↓

Sebaceous gland maturity and size differ between psoriatic alopecia and alopecia areata.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Monoclonal antibodies are often linked to alopecia areata cases.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

People with alopecia who are more resilient tend to feel less stressed.

People with alopecia areata in German-speaking countries spend a lot on their condition, with hair products and treatments being the most costly.

Alopecia areata affects 1.2% to 2.3% of Australians, with many unaware of treatment options.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Adolescents with alopecia areata face more bullying and emotional challenges, needing support to improve their quality of life.

Iron profile tests are recommended for women with hair loss, as haemoglobin levels alone are not reliable.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Yellow dots were the most common sign of alopecia areata found using trichoscopy.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Healthcare access for alopecia areata in the USA is unequal among ethnic groups.

Alopecia areata patients often have undetected thyroid issues, so routine thyroid screening is recommended.

Alopecia Areata affects both genders almost equally, mostly on the scalp, with common signs like yellow dots and exclamation mark hairs, especially in young people.

Alopecia areata patients often have autoimmune disorders, especially thyroid issues.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

Alopecia areata significantly affects emotional well-being and quality of life, especially in younger adults.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Dermatologists often treat alopecia areata inconsistently, especially in children and advanced cases.

Younger patients with severe alopecia areata often have nail problems.

Patients with alopecia areata face high costs for wigs due to poor insurance coverage.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.